Drug Approval | March 02, 2022
USFDA approves first generic version of Apokyn cartridges
TruPharma has commenced commercial marketing of Sage's approved generic cartridge product
TruPharma has commenced commercial marketing of Sage's approved generic cartridge product
First of three Amneal biosimilars expected for U.S. approval and launch in 2022
If approved, Opdivo plus chemotherapy would be the first neoadjuvant immunotherapy-based option for patients with resectable non-small cell lung cancer in the U.S.
Vonjo is the first approved therapy to specifically address the needs of adult cytopenic myelofibrosis patients
It is the first approved blood test that can predict likely progression to Alzheimer's Disease up to six years in advance
Boehringer Ingelheim plans to study this novel investigational therapy in patients with progressive fibrosing interstitial lung diseases
Jardiance is the first and only heart failure therapy to demonstrate a statistically significant risk reduction in cardiovascular death or hospitalization for heart failure, regardless of ejection fraction
Fyarro added to NCCN guidelines as the only preferred mTOR inhibitor to treat malignant PEComa
New InterStim X system provides 10 to 15 years of battery life without the need to recharge
New expanded indication provides patients suffering from earlier stages of heart failure access to the CardioMEMS HF System, a small implantable sensor that can flag early warning signs of worsening heart failure
Subscribe To Our Newsletter & Stay Updated
